Kura Oncology Inc
Ownership
Ownership Structure
Who owns Kura Oncology Inc (KURA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 79.3% of the shares are freely tradable; institutional investors hold 96.4%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 11.81 | 10,509,233 | +9.0 | 06/30/2026 |
| Suvretta Capital Management, LLC | 9.64 | 8,575,422 | +0.0 | 06/30/2026 |
| Bvf Inc | 9.49 | 8,445,769 | +0.0 | 06/30/2026 |
| State Street Corp | 5.99 | 5,329,208 | +18.1 | 06/30/2026 |
| Vanguard Capital Management, LLC | 4.40 | 3,916,164 | +3.4 | 06/30/2026 |
| Armistice Capital, LLC | 4.13 | 3,678,000 | -1.6 | 06/30/2026 |
| AQR Capital Management LLC | 3.51 | 3,126,727 | +47.2 | 06/30/2026 |
| The Goldman Sachs Group Inc | 2.55 | 2,265,171 | +58.0 | 06/30/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard MStar Total Stk Mkt Idx Invest | 3.15 | 2,799,338 | +0.0 | 09/30/2026 |
| State Street® SPDR® S&P® Biotech ETF | 2.88 | 2,558,010 | -1.9 | 09/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Wilson Troy Edward | President and CEO | 479,194 | 3,258,519 $ | Aug 24, 2026 | indirect |
| Bair Teresa Brophy | Chief Legal Officer | 187,002 | 1,271,614 $ | Sep 28, 2026 | direct |
| Ford Kathleen | Chief Operating Officer | 142,986 | 972,305 $ | Sep 29, 2026 | direct |
| Doyle Thomas James | SVP, Finance & Accounting | 142,428 | 968,510 $ | Sep 28, 2026 | direct |
| Leoni Mollie | Chief Medical Officer | 141,095 | 959,446 $ | Sep 29, 2026 | direct |
| Powl Brian T. | Chief Commercial Officer | 136,819 | 930,369 $ | Sep 29, 2026 | direct |
| Burrows Francis | Chief Scientific Officer | 42,327 | 287,824 $ | Sep 24, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 29, 2026 | Ford Kathleen | Chief Operating Officer | Sell | 3,668 | 10.75 | 39,437 |
| Sep 29, 2026 | Leoni Mollie | Chief Medical Officer | Sell | 28,802 | 10.75 | 309,567 |
| Sep 29, 2026 | Powl Brian T. | Chief Commercial Officer | Sell | 15,430 | 10.75 | 165,852 |
| Sep 28, 2026 | Bair Teresa Brophy | Chief Legal Officer | Sell | 8,442 | 10.50 | 88,618 |
| Sep 28, 2026 | Ford Kathleen | Chief Operating Officer | Sell | 6,906 | 10.50 | 72,494 |
| Sep 28, 2026 | Leoni Mollie | Chief Medical Officer | Sell | 12,448 | 10.50 | 130,670 |
| Sep 28, 2026 | Doyle Thomas James | SVP, Finance & Accounting | Sell | 4,607 | 10.50 | 48,361 |
| Sep 28, 2026 | Powl Brian T. | Chief Commercial Officer | Sell | 8,000 | 10.56 | 84,498 |
| Sep 28, 2026 | Powl Brian T. | Chief Commercial Officer | Sell | 9,020 | 10.50 | 94,686 |
| Sep 24, 2026 | Burrows Francis | Chief Scientific Officer | Sell | 20,726 | 10.83 | 224,514 |
| Sep 24, 2026 | Burrows Francis | Chief Scientific Officer | Other | 30,000 | 6.15 | 184,500 |
| Aug 24, 2026 | Wilson Troy Edward | President and CEO | Buy | 100,000 | 12.39 | 1,239,000 |
| Aug 21, 2026 | Powl Brian T. | Chief Commercial Officer | Sell | 4,345 | 11.89 | 51,663 |
| Aug 19, 2026 | Bair Teresa Brophy | Chief Legal Officer | Sell | 31,487 | 12.63 | 397,681 |
| Aug 17, 2026 | Wilson Troy Edward | President and CEO | Buy | 100,000 | 11.12 | 1,112,000 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.